Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 7/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.47 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11179021 | 0.81 | KDM4E (0.50) | HPGDKDM4ETSHRALDH1A1HSD17B10 | |
| SCHEMBL8411463 | 0.80 | KDM4E (0.48) | HPGDKDM4ETSHRALDH1A1HSD17B10 | |
| SCHEMBL10824784 | 0.80 | KDM4E (0.48) | HPGDKDM4ETSHRALDH1A1HSD17B10 | |
| SCHEMBL8411467 | 0.80 | KDM4E (0.48) | HPGDKDM4ETSHRALDH1A1HSD17B10 | |
| SCHEMBL29524852 | 0.79 | KDM4E (0.52) | HPGDKDM4ETSHRALDH1A1HSD17B10 | |
| SCHEMBL30367223 | 0.79 | KDM4E (0.48) | HPGDKDM4ETSHRALDH1A1HSD17B10 | |
| SCHEMBL726909 | 0.76 | KDM4E (0.46) | HPGDKDM4ETSHRALDH1A1HSD17B10 | |
| SCHEMBL11575219 | 0.76 | KDM4E (0.48) | HPGDKDM4ETSHRALDH1A1HSD17B10 | |
| SCHEMBL11575221 | 0.76 | KDM4E (0.48) | HPGDKDM4ETSHRALDH1A1HSD17B10 | |
| SCHEMBL11349279 | 0.75 | SLC7A5 (0.57) | HPGDKDM4ETSHRALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080293155-A1 | SALICYLAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS | THE REGENTS OF THE UNIVERISTY OF CALIFORNIA (US) | 2008-11-27 | — | — | US | disclosed |
| US-7404912-B2 | Salicylamide-lanthanide complexes for use as luminescent markers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-07-29 | — | — | US | disclosed |
| US-20060286567-A1 | Salicylamide-lanthanide complexes for use as luminescent markers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-12-21 | — | — | US | disclosed |
| US-7018850-B2 | Salicylamide-lanthanide complexes for use as luminescent markers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-03-28 | — | — | US | disclosed |
| EP-1154991-B1 | SALICYLAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS | UNIV CALIFORNIA (US) | 2004-07-28 | — | — | EP | disclosed |
| US-20030027189-A1 | Salicylamide-lanthanide complexes for use as luminescent markers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-02-06 | — | — | US | disclosed |
| US-6406297-B1 | USED FOR DETECTING AND QUANTIFYING CHEMICAL, BIOCHEMICAL AND BIOLOGICAL SUBSTANCES AS ANALYTES IN RESEARCH AND DIAGNOSTIC MIXTURES. | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060286567-A1 | Salicylamide-lanthanide complexes for use as luminescent markers | SCLY, SSB, LIG3 | HPGD 1122/4885KDM4E 3308/4885TSHR 3100/4885 |
| US-20030027189-A1 | Salicylamide-lanthanide complexes for use as luminescent markers | SCLY, SSB, LIG3 | HPGD 1122/4885KDM4E 3308/4885TSHR 3100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.